|
|
"fresh~horses" <fresh~horses@xxxxxxxxxxxxx> wrote in message
news:1127315605.423022.91570@xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
> September 21, 2005
> Subject: Celebrex* (celecoxib) capsules
> Important Safety Information
>
>
http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/celebrex_3_hpc-cps_e.html
>
> Dear Health Care Professional,
>
> Pfizer Canada Inc., following discussions with Health Canada, would
> like to inform you of important new safety information for CELEBREX*
> (celecoxib) capsules. The Product Monograph for CELEBREX is being
> revised as outlined below.
>
Canada can save a lot of money and decrease GNP spent on health even more by
eliminating Health Canada and relying on the FDA. They do it anyway.
Vioxx was developed in Canada and sent to the US for approval first by the
FDA. Once they got FDA approval then they got it approved "fast track" by
Health Canada.
"The journal also criticized what it called the current emphasis at Health
Canada and the FDA on "partnerships with industry and rapid drug-approval."
This emphasis "conflicts with the public's expectation that these agencies
exist to protect them by restricting approval to drugs that have been
thoroughly tested and are likely to be free of serious risks."
But Dodds said "we certainly don't speak of partnering with industry. We
review industry submissions. . . . There isn't a default that we will
approve. We have a responsibility to review all of the information that
industry brings to us in a submission."
mediresource.sympatico.ca/health_news_detail.asp?channel_id=14&menu_item_id=&news_id=5648">http://mediresource.sympatico.ca/health_news_detail.asp?channel_id=14&menu_item_id=&news_id=5648
|
|